Making medicines sustainable

There’s a new cross-healthcare initiative to cut medicines waste and lower carbon emissions while also improving healthcare equity and serving patients. Pharma will be a key player

Patients and Medical

Reaching Gen-Z

Despite creditable ongoing efforts by pharma to represent the broadest and most diverse population of patients in research and care,...

Medical

Nurturing peer-to-peer interactions in a virtual world

As medical events pivoted from conference centers to virtual meeting rooms, learning opportunities continued. Lectures and presentations...

Latest

Access and Evidence
The future is bright for RWE in pharma approvals

Brian Eastwood, (Jan 6, 2022)

The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task
Medical
The shift towards digital technology for clinical research

Mary Nishikawa, (Dec 21, 2021)

Remote patient participation and trial monitoring can avoid the high risk of hospital visits
Medical
Pharma’s new leaders in field engagement: MSLs

Andrew Stone, (Nov 30, 2021)

With the whole of pharma in various states of ‘hybridisation’, how can MSLs be supported to deliver enhanced personal service across physical and virtual engagements?
Multichannel
Making medicines sustainable

Andrew Stone, (Nov 30, 2021)

There’s a new cross-healthcare initiative to cut medicines waste and lower carbon emissions while also improving healthcare equity and serving patients. Pharma will be a key player
Patients and Medical
Reaching Gen-Z

Risa Kerslake, (Nov 24, 2021)

Young people comprise a unique demographic that pharma is not used to serving but new digital tools offer ways to understand, engage and serve them better

Opinion

Up close and personal – The Dr. Kevin Williams story

Jill Donahue, (Jun 7, 2021)

Following in his physician father's footsteps, for this pharma leader it's always been about the patient

Up close and personal: Reacting in a crisis - The Naji Gehchan story

Jill Donahue, (Mar 11, 2021)

This pharma leader worked in a war zone. Now he’s using the same tactics to navigate the pandemic

More Columns

Commercial

Unlocking the full potential of biosimilars

Pamela Whitby, (Jul 2, 2021)

The future looks bright for biosimilars in an age of crisis over healthcare affordability
Accelerating commercial success in CAGT

Dean Griffiths, (Mar 22, 2021)

To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in
Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology
Creating a holistic customer experience

Rhonda Siddall, (Nov 17, 2020)

Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match

More Commercial

Access and Evidence

The future is bright for RWE in pharma approvals

Brian Eastwood, (Jan 6, 2022)

The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task
Payers and the ABCs of digital literacy

Katie Osborne, (Sep 24, 2021)

Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Decoding the patient journey with RWD

Lucy Fulford, (Jul 6, 2021)

Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise
Keeping it real: How data is driving healthcare reform in China

Pamela Whitby, (Jun 8, 2021)

China’s healthcare market is ripe for those capable of helping it capture the vast potential of real-world data
Including the caregiver in access submissions

Katie Osborne, (May 23, 2021)

Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence

More Market Access

Patients and Medical

Reaching Gen-Z

Risa Kerslake, (Nov 24, 2021)

Young people comprise a unique demographic that pharma is not used to serving but new digital tools offer ways to understand, engage and serve them better
Helping patients help themselves

Andrew Stone, (Nov 19, 2021)

Self care offers a new way for health care companies to serve patients better globally and industry collaboration will drive faster progress
Chiesi: Putting purpose at its heart

Andrew Stone, (Nov 10, 2021)

Italian pharma company Chiesi has embedded environmental and social purpose into its very corporate fabric
Medical Affairs & Social Media: A Brave New World

Andrew Stone, (Sep 17, 2021)

A great majority of healthcare providers now use social media platforms. Medical Affairs teams need to amplify their voice on social media channels – or lose out.
Optimizing patient Engagement in Trials

Joseph Constance, (May 23, 2021)

The importance of involving the patient at all stages of trials post-pandemic has never been clearer